Paul Edison Selected Research

Therapeutics

11/2012

Drug repositioning for Alzheimer's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul Edison Research Topics

Disease

33	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 07/2006
14	Cognitive Dysfunction 01/2022 - 01/2013
12	Neuroinflammatory Diseases 01/2021 - 05/2015
7	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 08/2011
6	Dementia (Dementias) 01/2022 - 08/2011
6	Disease Progression 01/2019 - 05/2015
5	Inflammation (Inflammations) 01/2020 - 02/2014
3	Parkinson Disease (Parkinson's Disease) 12/2015 - 05/2013
2	Atrophy 01/2022 - 07/2006
2	Insulin Resistance 01/2021 - 01/2016
2	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2019
2	Tauopathies 01/2019 - 01/2016
1	Normal Pressure Hydrocephalus 08/2021
1	Genetic Risk Score 01/2021
1	Prodromal Symptoms 01/2021
1	Multiple Sclerosis 10/2019
1	Obesity 01/2019
1	Encephalitis (Encephalitis, Rasmussen) 07/2017
1	Traumatic Brain Injuries (Traumatic Brain Injury) 03/2016
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2016
1	Corticobasal Degeneration 01/2016
1	Chronic Traumatic Encephalopathy 01/2016
1	Frontotemporal Dementia (Semantic Dementia) 01/2016
1	Pathologic Processes 12/2015
1	Hyperinsulinism (Hyperinsulinemia) 12/2015
1	Amyloid Plaque 11/2013
1	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 03/2012
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 03/2012
1	Huntington Disease (Huntington's Disease) 05/2007

Drug/Important Bio-Agent (IBA)

28	Amyloid (Amyloid Fibrils)IBA 01/2022 - 07/2006
9	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 10/2019 - 07/2006
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2015
7	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 05/2013
4	Proteins (Proteins, Gene)FDA Link 01/2018 - 05/2015
3	Insulin (Novolin)FDA Link 01/2021 - 02/2014
3	Liraglutide FDA Link 01/2020 - 12/2015
3	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2020 - 12/2015
3	PK 11195 (PK11195)IBA 06/2015 - 05/2007
2	Amyloid beta-PeptidesIBA 01/2022 - 01/2020
2	tau Proteins (tau Protein)IBA 01/2019 - 01/2016
2	Neuroprotective AgentsIBA 01/2019 - 01/2018
2	Apolipoprotein E4IBA 01/2018 - 05/2015
1	4- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA 10/2021
1	ApolipoproteinsIBA 01/2021
1	LipidsIBA 01/2021
1	(methyl- (11)C)N- acetyl- N- (2- methoxybenzyl)- 2- phenoxy- 5- pyridinamineIBA 01/2018
1	CytokinesIBA 01/2017
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2017
1	THK5351IBA 01/2016
1	7- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA 01/2016
1	LigandsIBA 01/2016
1	lixisenatideIBA 12/2015
1	Insulin ReceptorIBA 12/2015
1	Exenatide (Byetta)FDA Link 12/2015
1	(R)- (11C)1- (2- chlorophenyl)- N- methyl- N- (1- methylpropyl)- 3- isoquinolinecarboxamideIBA 09/2015
1	isoquinolineIBA 06/2015
1	Pharmaceutical PreparationsIBA 11/2012
1	Presenilin-1IBA 01/2011

Therapy/Procedure

1	Activities of Daily Living (ADL) 01/2019
1	Therapeutics 11/2012